DexCom's Q4 Beat And 2026 Targets Tested By Rising CGM Competition [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
DexCom reported strong preliminary Q4 results, with topline figures above its earlier expectations. The company paired this update with a positive outlook for 2026, outlining targets that support its longer term growth plans. These announcements come as competition in glucose monitoring intensifies and recent analyst views on NasdaqGS:DXCM have turned more mixed. DexCom, traded as NasdaqGS:DXCM, last closed at $73.04. The stock is up 9.8% over the past month and 9.8% year to date, but it has seen a 15.9% decline over the past year and a 32.6% decline over three years. Those swings set the backdrop for how investors may read the latest Q4 update and guidance. For investors, the key question is how the stronger preliminary Q4 numbers and 2026 outlook compare with rising competitive pressures. The market reaction from here may depend on whether DexCom can continue to translate its product position into revenue growth while defending share in a more crowded field. Stay updated
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive [Yahoo! Finance]Yahoo! Finance
- What DexCom (DXCM)'s Strong Q4 Beat and 2026 Margin Guidance Means For Shareholders [Yahoo! Finance]Yahoo! Finance
- HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments [Yahoo! Finance]Yahoo! Finance
- Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.Business Wire
DXCM
Earnings
- 10/30/25 - Beat
DXCM
Sec Filings
- 2/2/26 - Form 4
- 2/2/26 - Form 4
- 2/2/26 - Form 4
- DXCM's page on the SEC website